Retirement Wealth Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.4K Sell
255
-1
-0.4% -$152 0.02% 131
2026
Q2
$40.1K Hold
256
– – 0.02% 109
2026
Q1
$39.1K Sell
256
-21
-8% -$3.22K 0.02% 99
2025
Q4
$38.2K Hold
277
– – 0.02% 107
2025
Q3
$35.5K Buy
277
+42
+18% +$5.13K 0.02% 113
2025
Q2
$28.4K Hold
235
– – 0.02% 125
2025
Q1
$26.2K Buy
235
+6
+3% +$639 0.02% 113
2024
Q4
$22.7K Buy
+229
New +$24.4K 0.02% 134

Other funds holding NVS

Retirement Wealth Solutions's NVS Position: Q3 2026 in Review

Retirement Wealth Solutions reduced its Novartis (NVS) stake by 0.39% in Q3 2026, selling an estimated $152 and leaving 255 shares worth $36.4K. The position accounts for 0.02% of the portfolio, ranked #131.

Retirement Wealth Solutions first reported a position in NVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $40.1K in Q2 2026. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Retirement Wealth Solutions held 255 shares of Novartis worth $36.4K as of Q3 2026.
  • Retirement Wealth Solutions sold 1 Novartis share in Q3 2026, an estimated $152.
  • Novartis made up 0.02% of Retirement Wealth Solutions's portfolio in Q3 2026, its #131 holding.
  • Retirement Wealth Solutions first reported a position in Novartis in Q4 2024 and has held it in 8 quarters since.
  • Retirement Wealth Solutions's Novartis position peaked at $40.1K in Q2 2026.
  • 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Retirement Wealth Solutions's 13F filing for Q3 2026, filed 7 Oct 2026.